UNSPSC 85533456: Supplement left external iliac vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left external iliac vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UG4JZ

UNSPSC 85533456 Supplement left external iliac vein with synthetic substitute, percutaneous endoscopic approach is a Commodity code that shows no relevant recent state and local procurement activity. The code describes a highly specific vascular surgical procedure, but the recent opportunities posted under this classification do not involve vascular surgery, medical device implants, or procedural supplies. Instead, the opportunities tagged to this code cover independent medical evaluation services, pharmacy benefit management, occupational health surveillance, temporary health professional staffing, and surgical benefit carve-out programs—none of which involve vein supplementation or synthetic vascular grafts. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the state and local procurement system or that this code is not actively used for genuine vascular procedure procurement at the state and local level.

The issuing bodies posting opportunities under this code include city retirement offices (City of Phoenix), municipal health plans (City of Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile probation departments (Harris County), county commissioners (Collier County), and county health systems (County of Santa Clara). Geographic spread includes Arizona, California, Washington, Texas, and Florida. No single jurisdiction appears as a repeat buyer under this code, and the opportunities themselves bear no operational relationship to vascular surgical procedure supply or implantation. Given the absence of authentic procurement activity aligned with the code's definition, this code presents no actionable market signal for business development targeting state and local vascular device or surgical procedure supply.